SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001144204-17-048499
Filing Date
2017-09-18
Accepted
2017-09-18 16:16:25
Documents
2
Group Members
DAVID HIRSCHJULIET TAMMENOMS BAKKERLONGITUDE VENTURE PARTNERS III, L.P.PATRICK G. ENRIGHT

Document Format Files

Seq Description Document Type Size
1 SC 13D v475291_sc13d.htm SC 13D 110869
2 EXHIBIT 1 v475291_ex-1.htm EX-99.1 8436
  Complete submission text file 0001144204-17-048499.txt   121059
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Subject) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-81377 | Film No.: 171090083
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 EL CAMINO, SUITE 220 MENLO PARK CA 94025
Business Address 800 EL CAMINO, SUITE 220 MENLO PARK CA 94025 650-845-5700
Longitude Capital Partners III, LLC (Filed by) CIK: 0001713663 (see all company filings)

IRS No.: 811668051 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D